U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07738952) titled 'Safety and Efficacy Study of Sivelestat in Neuromyelitis Optica Spectrum Disorder' on July 17.
Brief Summary: The primary objective of this study is to evaluate the safety and tolerability of sivelestat sodium hydrate administered in combination with standard steroid pulse therapy in patients experiencing an acute NMOSD attack. Safety assessments will include adverse events, laboratory parameters, vital signs, and other clinically relevant findings. In addition, the study will explore whether the addition of sivelestat sodium hydrate to standard steroid pulse therapy improves neurological outcomes in patients with acute NMOSD.
Parti...